Avricore Health Inc (AVCR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avricore Health Inc (AVCR) has a cash flow conversion efficiency ratio of -0.236x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-305.21K ≈ $-220.79K USD) by net assets (CA$1.29 Million ≈ $935.63K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Avricore Health Inc - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Avricore Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AVCR total debt and obligations for a breakdown of total debt and financial obligations.
Avricore Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avricore Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vestand Inc.
NASDAQ:VSTD
|
-0.192x |
|
Eversafe Rubber Bhd
KLSE:0190
|
0.124x |
|
Better Choice Company Inc
NYSE MKT:BTTR
|
0.048x |
|
Rayong Wire Industries Public Company Limited
BK:RWI
|
0.057x |
|
Tarapur Transformers Limited
NSE:TARAPUR
|
1.083x |
|
Davis Commodities Limited Ordinary Shares
NASDAQ:DTCK
|
-0.327x |
|
Nanologica AB
ST:NICA
|
-0.417x |
|
Hubify Ltd
AU:HFY
|
0.055x |
Annual Cash Flow Conversion Efficiency for Avricore Health Inc (2000–2024)
The table below shows the annual cash flow conversion efficiency of Avricore Health Inc from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Avricore Health Inc (AVCR) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$1.97 Million ≈ $1.42 Million |
CA$1.00 Million ≈ $726.72K |
0.511x | +55.31% |
| 2023-12-31 | CA$2.01 Million ≈ $1.45 Million |
CA$660.40K ≈ $477.73K |
0.329x | +247.46% |
| 2022-12-31 | CA$1.96 Million ≈ $1.42 Million |
CA$-437.83K ≈ $-316.72K |
-0.223x | +60.32% |
| 2021-12-31 | CA$2.20 Million ≈ $1.59 Million |
CA$-1.23 Million ≈ $-892.77K |
-0.562x | -132.79% |
| 2020-12-31 | CA$-714.04K ≈ $-516.53K |
CA$-1.22 Million ≈ $-884.99K |
1.713x | +16.18% |
| 2019-12-31 | CA$-465.45K ≈ $-336.70K |
CA$-686.41K ≈ $-496.54K |
1.475x | +175.74% |
| 2018-12-31 | CA$885.97K ≈ $640.89K |
CA$-1.73 Million ≈ $-1.25 Million |
-1.947x | -175.22% |
| 2017-12-31 | CA$2.50 Million ≈ $1.81 Million |
CA$-1.77 Million ≈ $-1.28 Million |
-0.707x | +34.26% |
| 2016-12-31 | CA$1.92 Million ≈ $1.39 Million |
CA$-2.06 Million ≈ $-1.49 Million |
-1.076x | -81.28% |
| 2015-12-31 | CA$3.25 Million ≈ $2.35 Million |
CA$-1.93 Million ≈ $-1.39 Million |
-0.594x | -34.10% |
| 2014-12-31 | CA$3.35 Million ≈ $2.43 Million |
CA$-1.48 Million ≈ $-1.07 Million |
-0.443x | +45.59% |
| 2013-12-31 | CA$663.10K ≈ $479.67K |
CA$-539.52K ≈ $-390.28K |
-0.814x | -129.81% |
| 2012-12-31 | CA$436.69K ≈ $315.89K |
CA$-154.61K ≈ $-111.84K |
-0.354x | -897.35% |
| 2011-12-31 | CA$-1.32 Million ≈ $-955.71K |
CA$-58.66K ≈ $-42.44K |
0.044x | -92.97% |
| 2010-12-31 | CA$-1.07 Million ≈ $-771.49K |
CA$-673.34K ≈ $-487.08K |
0.631x | +104.18% |
| 2009-12-31 | CA$239.30K ≈ $173.10K |
CA$-3.61 Million ≈ $-2.61 Million |
-15.095x | -2699.35% |
| 2008-12-31 | CA$1.73 Million ≈ $1.25 Million |
CA$-930.62K ≈ $-673.20K |
-0.539x | -52.29% |
| 2007-12-31 | CA$2.48 Million ≈ $1.79 Million |
CA$-876.72K ≈ $-634.21K |
-0.354x | +25.57% |
| 2006-12-31 | CA$779.90K ≈ $564.17K |
CA$-371.02K ≈ $-268.39K |
-0.476x | +76.21% |
| 2005-12-31 | CA$157.37K ≈ $113.84K |
CA$-314.66K ≈ $-227.62K |
-1.999x | -33.90% |
| 2004-12-31 | CA$271.03K ≈ $196.06K |
CA$-404.72K ≈ $-292.77K |
-1.493x | -58.17% |
| 2003-12-31 | CA$800.22K ≈ $578.87K |
CA$-755.46K ≈ $-546.49K |
-0.944x | -1330.14% |
| 2002-12-31 | CA$182.98K ≈ $132.37K |
CA$14.04K ≈ $10.16K |
0.077x | +119.37% |
| 2001-12-31 | CA$184.42K ≈ $133.41K |
CA$-73.06K ≈ $-52.85K |
-0.396x | -202.19% |
| 2000-12-31 | CA$79.95K ≈ $57.83K |
CA$-10.48K ≈ $-7.58K |
-0.131x | -- |
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018… Read more